Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.50    0.00 (0.00%)
Bid:
104.50
Ask:
106.00
Spread: 1.50 (1.435%)
Market Cap: £305.38m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Litigation Update

21 Mar 2025 11:13

RNS Number : 7010B
Big Technologies PLC
21 March 2025
 

21 March 2025

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

Litigation Update

Further to the announcement released by the Company at 12:51 p.m. on 18 March 2025 (the "18 March Announcement"), the Company provides the following update on the Litigation (as defined in the 18 March Announcement) and other matters arising from its investigations. 

 

The Company's further investigations have resulted in the Board becoming aware of information which means that the Company can no longer rely on the statement signed by Sara Murray on behalf of the Company in the Litigation, where that relates to her interests in, and relationship with, Zinc Limited, Monitoring Partners Limited, RCP Limited and Romelle Limited. Together, these four entities held ordinary shares in the Company ("BIG Shares") at the time of the Company's Admission to AIM on 28 July 2021 ("Admission") representing approximately 17.7% of the issued share capital of the Company at that time.

 

As part of its continuing investigations, the Company has asked Sara Murray to clarify the exact nature of her interests in and relationship with the four entities referred to above.

Sarah Murray held BIG Shares at Admission representing approximately 25.3% of the Company's issued share capital at Admission. Since that time she has made a number of purchases of BIG Shares and has been issued further BIG Shares pursuant to the Company's Growth Share Plan, resulting in her current direct holding representing 26.8% of the current issued share capital of the Company.

 

In light of the information from its further investigations, the Company is considering its position in relation to the Litigation as well as other steps which it may be appropriate to take, including the possibility of claims or actions against and in relation to Sara Murray and others.

 

In the meantime, the company's investigations in relation to Sara Murray's conduct continue and the Company will provide further updates as appropriate. 

For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Alexander Brennan (Interim Chairman)

Daren Morris (Interim Chief Executive Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDMZGZFMMZGKZM
Date   Source Headline
4th Dec 202312:40 pmRNSEBT Share Purchase
20th Nov 202310:58 amRNSEBT Share Purchase
10th Nov 20239:08 amRNSDirector/PDMR Shareholding
8th Nov 20231:48 pmRNSEBT Share Purchase
1st Nov 20231:42 pmRNSEBT Share Purchase
25th Oct 202310:22 amRNSDirector/PDMR Shareholding
24th Oct 20234:57 pmRNSDirector/PDMR Shareholding - Replacement
24th Oct 202312:23 pmRNSDirector/PDMR Shareholding
24th Oct 202311:55 amRNSDirector/PDMR Shareholding - Replacement
23rd Oct 20235:05 pmRNSDirector/PDMR Shareholding
23rd Oct 20235:03 pmRNSEBT Share Purchase
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20239:05 amRNSIncrease in Share Capital
11th Oct 20231:40 pmRNSEBT Share Purchase
10th Oct 202311:40 amRNSEBT Share Purchase
3rd Oct 20237:00 amRNSEBT Share Purchase
28th Sep 20237:00 amRNSEBT Share Purchase
21st Sep 20237:00 amRNSEstablishment of an Employee Benefit Trust
19th Sep 20237:00 amRNSHalf-year Report
4th Aug 20238:57 amRNSStatement re legal claim
18th Jul 20237:00 amRNSIncrease in share capital and director dealing
7th Jun 20237:00 amRNSIncrease in share capital
23rd May 20231:43 pmRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
17th May 20232:10 pmRNSIncrease in Share Capital
26th Apr 20231:40 pmRNS2022 Annual Report and Notice of AGM
21st Apr 202310:27 amRNSDirector/PDMR Shareholding
5th Apr 20231:04 pmRNSDirector/PDMR Shareholding
4th Apr 202312:27 pmRNSDirector/PDMR Shareholding
31st Mar 202312:12 pmRNSIncrease in Share Capital
29th Mar 20237:00 amRNS2022 Preliminary audited results
23rd Mar 20231:01 pmRNSHolding(s) in Company
20th Jan 20237:00 amRNSTrading Statement
8th Dec 202212:38 pmRNSIncrease in share capital
18th Oct 20227:00 amRNSIncrease in share capital
20th Sep 20227:00 amRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSHalf-year Report
14th Sep 20224:48 pmRNSHolding(s) in Company
13th Sep 20224:36 pmRNSPrice Monitoring Extension
6th Sep 20224:40 pmRNSSecond Price Monitoring Extn
6th Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20224:40 pmRNSSecond Price Monitoring Extn
26th Aug 20224:35 pmRNSPrice Monitoring Extension
1st Aug 20224:36 pmRNSPrice Monitoring Extension
1st Aug 20222:03 pmRNSDirector/PDMR Shareholding
1st Aug 202211:50 amRNSIncrease in share capital
25th Jul 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:19 pmRNSIncrease in share capital
16th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.